Compare
Align Technology vs Haemonetics (ALGN vs HAE)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Align Technology (ALGN) returned +21.0% and Haemonetics (HAE) +136.5%; so far this year the figures are +6.3% and +49.6%.
Align Technology is the larger company by market value, about 2.1 times the size of Haemonetics.
On trailing earnings, ALGN trades at 24.2 times and HAE at 53.1 times.
Revenue grew +4.4% at ALGN and +4.1% at HAE over the last year.
Data as of the latest close. Not investment advice.
Relative performance
| ALGN | HAE | |
|---|---|---|
| Price | $166.00 | $119.93 |
| 1-day | +4.16% | -3.37% |
| YTD | +6.31% | +49.63% |
| 1 year | +20.98% | +136.46% |
| 3 years | -9.39% | +38.82% |
| Market cap | $11.7B | $5.5B |
| P/E | 24.2 | 53.1 |
| P/S | 2.81 | 3.95 |
| P/B | 2.72 | 6.08 |
| Revenue growth | +4.40% | +4.10% |
| EPS growth | +32.90% | -33.90% |
| Gross margin % | 69.1 | 59.6 |
| Net margin % | 11.8 | 7.5 |
| ROE % | 11.4 | 11.6 |
| Debt / equity | 0.00 | 1.25 |
| FCF yield % | 5.1 | 5.5 |
| Dividend yield % | — | — |
| Beta | 1.32 | 0.14 |
| RSI (14) | 64.7 | 55.5 |
| Technical rating |